273 related articles for article (PubMed ID: 21323408)
1. Recurrent episodes of very late stent thrombosis in a patient with aspirin hypersensitivity, stent fracture and malapposition.
Barison A; de Carlo M; Bellini F; Capozza PF; Lunardini A; Petronio AS
Acute Card Care; 2011 Mar; 13(1):52-4. PubMed ID: 21323408
[TBL] [Abstract][Full Text] [Related]
2. Very late drug-eluting stent thrombosis in a patient with an INR of 4.4.
Candemir B; Güleç S; Ozdemir AO; Kumbasar D
Turk Kardiyol Dern Ars; 2010 Dec; 38(8):561-3. PubMed ID: 21248458
[TBL] [Abstract][Full Text] [Related]
3. Tailored medical and interventional therapy against recurrent stent thrombosis after drug-eluting stenting.
Campo G; Valgimigli M; Carrescia C; Carletti R; Ferrari R
Clin Appl Thromb Hemost; 2010 Oct; 16(5):591-3. PubMed ID: 19520678
[TBL] [Abstract][Full Text] [Related]
4. Very late stent thrombosis after dual antiplatelet therapy discontinuation in a patient with a history of acute stent thrombosis.
Bhatt SH; Hauser TH
Ann Pharmacother; 2008 May; 42(5):708-12. PubMed ID: 18381843
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
[TBL] [Abstract][Full Text] [Related]
6. Very late thrombosis of sirolimus-eluting stent due to late malapposition: serial observations with optical coherence tomography.
Sawada T; Shite J; Shinke T; Tanino Y; Ogasawara D; Kawamori H; Kato H; Miyoshi N; Yoshino N; Hirata K
J Cardiol; 2008 Dec; 52(3):290-5. PubMed ID: 19027609
[TBL] [Abstract][Full Text] [Related]
7. Late stent thrombosis of a second-generation drug- eluting stent.
Karjalainen PP; Nammas W; Ylitalo A
J Invasive Cardiol; 2012 Oct; 24(10):E225-7. PubMed ID: 23043049
[TBL] [Abstract][Full Text] [Related]
8. A current problem in cardiology: very late thrombosis after implantation of sirolimus eluting stent.
Sharifkazemi MB; Zamirian M; Aslani A
Cardiology; 2007; 108(4):273-4. PubMed ID: 17114881
[TBL] [Abstract][Full Text] [Related]
9. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
[TBL] [Abstract][Full Text] [Related]
10. Late stent thrombosis after paclitaxel-eluting stent placement in a patient with essential thrombocytosis.
Keleş T; Bayram NA; Durmaz T; Bozkurt E
Turk Kardiyol Dern Ars; 2010 Dec; 38(8):558-60. PubMed ID: 21248457
[TBL] [Abstract][Full Text] [Related]
11. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
[TBL] [Abstract][Full Text] [Related]
12. Subacute stent thrombosis owing to complete clopidogrel resistance successfully managed with prasugrel.
Flaherty MP; Johnston PV; Rade JJ
J Invasive Cardiol; 2011 Jul; 23(7):300-4. PubMed ID: 21725128
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
[TBL] [Abstract][Full Text] [Related]
14. [Coronary artery bypass grafting for simultaneous subacute stent thrombosis after sirolimus-eluting stent implantation].
Matsumoto M; Suehiro K; Kubo Y; Onoue G; Komatsubara I; Seito T; Morimoto N; Shiraishi K; Kasai S; Hagioka S; Naito H; Nagae M
Kyobu Geka; 2008 May; 61(5):355-8. PubMed ID: 18464477
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of modified dual antiplatelet therapy combined with warfarin following percutaneous coronary intervention with drug-eluting stents.
Baber U; Akhter M; Kothari S; Sharma SK; Kini A
J Invasive Cardiol; 2010 Feb; 22(2):80-3. PubMed ID: 20124594
[TBL] [Abstract][Full Text] [Related]
16. Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.
Roy P; Bonello L; Torguson R; Okabe T; Pinto Slottow TL; Steinberg DH; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2009 Mar; 103(6):801-5. PubMed ID: 19268735
[TBL] [Abstract][Full Text] [Related]
17. High maintenance dosage of clopidogrel is associated with a reduced risk of stent thrombosis in clopidogrel-resistant patients.
Tavassoli N; Voisin S; Carrie D; Lapeyre-Mestre M; Galinier M; Montastruc JL; Pathak A
Am J Cardiovasc Drugs; 2010; 10(1):29-35. PubMed ID: 20104932
[TBL] [Abstract][Full Text] [Related]
18. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Jia de A; Cao Z; Nie B; Ge HL; Yang SW; Yan ZX
Thromb Res; 2009 May; 124(1):46-51. PubMed ID: 19041120
[TBL] [Abstract][Full Text] [Related]
19. Use of prasugrel in a patient with clopidogrel hypersensitivity.
Peppard SR; Held-Godgluck BM; Beddingfield R
Ann Pharmacother; 2011 Oct; 45(10):e54. PubMed ID: 21896923
[TBL] [Abstract][Full Text] [Related]
20. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
